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Abstract 
Introduction: An important task of experimental and clinical pharmacology and ophtalmology is to find highly effective 
drugs for correcting retinal ischemia. 
Objective: Improving the pharmacological correction efficiency of the retinal ischemia-reperfusion with use the new 
substances related to imidazoline receptor ligands. 
Materials and methods: The retinal ischemia-reperfusion model in rats was used, in which an increase in intraocular 
pressure is carried out by mechanical pressure to the front chamber of the eye for 30 min. The protective effects of the 
studied imidazoline receptor ligands: sodium salt of C7070, potassium salt of C7070 were evaluated based on the results of 
semi-quantitative assessment of the eye fundus condition during ophthalmoscopy and counting the specific number of 
neuronal nuclei in the inner nuclear layer. 
Results and Discussion: The most pronounced protective effect is demonstrated by potassium salt of C7070 in a dose of 
10 mg/kg, which is expressed in reaching the target values of the semi-quantitative assessment of the eye fundus condition 
and the specific number of neuronal nuclei in the inner nuclear layer. When the pathology is corrected with sodium salt of 
C7070 in a dose of 10 mg/kg, the semi-quantitative assessment of the eye fundus condition in the group decreased by 
71.4% (p < 0.05), specific number of neuronal nuclei in the inner nuclear layer increased by 74,6% (p < 0.05) compared 
with the group without correction.  
Conclusion: The obtained data give an experimental substantiation of the pharmacological correction possibility of retinal 
ischemia-reperfusion by imidazoline receptor ligands. 
Keywords: Imidazoline Receptor Ligands, Sodium Salt of C7070, Potassium Salt of C7070, Retinal Ischemia-Reperfusion 
Model, Rats. 
 
Introduction 
Nonarteritic anterior ischemic optic neuropathy 
(NAION), acute ischemia of the anterior segment of 
the optic nerve, occurs 6 times more often compared 
with developed against the background of systemic 
vasculitis. The prevalence of the disease is 2.3-10.2 
per 100 000 population over 50 years [1]. 
In the base of ischemic optic neuropathy is an 
acute violation of arterial blood circulation in the 
system of vessels feeding the optic nerve [2]. 
Biochemical, hemodynamic disorders that develop in 
atherosclerosis, hypertension, diabetes mellitus, blood 
diseases, arterial (brachiocephalic, etc.) occlusions 
play a leading role in the development of this 
pathology [3]. 
Studying the way of how to improve retinal tissue 
tolerance to ischemia is an actual problem of 
pharmacology. Up to now, the treatment of ischemic 
retinal conditions was done by use of angioprotectors, 
antioxidants, fibrinolytics, and others. Due to the 
instability effects after using these drugs it is 
necessary to seek out more effective ways to improve 
blood circulation in retina and increase resistance to 
ischemic retinal tissue having a specific orientation [4, 
5]. Therefore, an important task is to find specific and 
highly effective agents for the treatment of retinal 
ischemia. 
Imidazoline receptors (IR) of type II are a new 
target for the correction of neurological disorders [6]. 
IR of type II are widely distributed in the brain, and 
their agonists are potential neuroprotectors [7, 8]. 
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IR of type III regulate the K+ and Ca2+ 
concentrations in cells and are associated with the 
activation of ATP-dependent potassium channels [9], 
which is expected to have a positive effect in the 
correction of ischemia, in particular, in the retina. 
To study the pharmacological activity of new 
biologically active substances [10], as well as study 
the new effects of already known drugs [11], it is 
necessary to conduct experimental studies in vitro and 
in vivo [12]. 
Thus, it is important to study the possibilities of 
pharmacological correction of retinal ischemia with 
use the imidazoline receptor ligands in vivo. 
Objective of the study is improving the 
pharmacological correction efficiency of the retinal 
ischemia-reperfusion in vivo with use the imidazoline 
receptor ligands: sodium salt of C7070, potassium salt 
of C7070. 
Materials and Methods 
Experiments were carried out on 60 rats Wistar 
weighing 225-275 g. For the study, the rats were taken 
with no external signs of disease, having passed the 
quarantine regime. Ethical principles of handling 
laboratory animals were observed in accordance with 
the European Convention for the Protection of 
Vertebrate Animals Used for Experimental and Other 
Scientific Purposes, CETS No. 123. 
The following experimental groups were 
included: 
The first (n = 10) – an intact group;  
The second (n = 10) – a group with the simulated 
retinal ischemia-reperfusion; 
The third (n = 10) – a group with correction of the 
retinal ischemia-reperfusion by potassium salt of 
C7070 in a dose of 10 mg/kg;  
The fourth (n = 10) – a group with the correction 
by sodium salt of C7070 in a dose of 10 mg/kg; 
The fifth (n = 10) – a group with the correction by 
potassium salt of C7070 in a dose of 10 mg/kg + 
glibenclamide in a dose of 5 mg/kg; 
The sixth (n = 10) – a group with the correction by 
sodium salt of C7070 in a dose of 10 mg/kg + 
glibenclamide in a dose of 5 mg/kg. 
Retinal ischemia-reperfusion was simulated under 
general anesthesia with use the chloral hydrate in a 
dose of 300 mg/kg, intraperitoneally (i.p.) by applying 
mechanical pressure up to 110 mm Hg, to the anterior 
eye chamber for 30 min [13].The potassium salt of 
С7070 (the potassium salt of 3-(1H-benzimidazol-2-
il)-1,2,2-trimethyl cyclopentancarbonic acid) with 
laboratory code K+C7070 («JSC Experimental Plant 
VladMiVa», Belgorod, Russia) was injected 
intragastrically (i.g.) in a dose of 10 mg/kg as a single 
injection 60 min before the retinal ischemia 
simulation. The sodium salt of С7070 (the sodium salt 
of 3-(1H-benzimidazol-2-il)-1, 2, 2-trimethyl 
cyclopentancarbonic acid) with laboratory code 
Na+C7070 («JSC Experimental Plant VladMiVa», 
Belgorod, Russia) was injected i.g. in a dose of 10 
mg/kg as a single injection 60 min before the retinal 
ischemia simulation. Glibenclamide was administered 
in a dose of 5 mg/kg i.g. once 1 hour before retinal 
ischemia-reperfusion simulation. 
Ophthalmoscopy. The rats were anesthetized to 
perform ophthalmoscopy after 72 hours of 
reperfusion. To dilate the pupils, Irifrin eye drops 
2.5% were used. The ophthalmoscope (Bx a Neitz, 
Japan) was brought closer to the rat’s eye and a beam 
of light was directed at the eye from a distance of 0.5–
2.0 cm to obtain a clear eye fundus image. An Ocular 
Osher MaxField 78D, model OI-78M (Volk Optical 
Inc, Mentor, OH, USA), was used to magnify and 
obtain photos of the eye fundus (Peresyp RRP). 
For further statistical processing, the degree of 
changes in the eye fundus caused by ischemia-
reperfusion detected by ophthalmoscopy was ranked 
(Table 1). 
 
Table-1: Method of Semi-quantitative Assessment of Changes in the Eye Fundus Caused by Retinal 
Ischemia-Reperfusion, points 
Features of eye fundus changes Score 
Norm. The optic disc (OD) is round or oval, and against the background of the fundus its colour is pale pink. The 
boundaries of OD are clear. It is located in the plane of the retina. Out of the middle of the OD come the central vessels 
of the retina. Retinal vessels have no anastomoses. Veins and arteries are straight, the caliber is uniform, with no 
tortuosity. The overall background is pink. 
0 
Correction of neuronal damage. The OD is round or oval, and against the background of the fundus its colour is pale 
pink. The boundaries of OD are clear. It is located in the plane of the retina. There are spasm of arteries (filamentous 
arteries), dilation and tortuosity of veins, microaneurysms. 
1 
Correction of vascular damage. Retinal vessels have no anastomoses. Veins and arteries are straight, the caliber is 
uniform, with no tortuosity. Obvious OD decoloration. Edema of the OD and peripapillary retina. The boundaries of OD 
are not clear. 
2 
Retinal ischemia-reperfusion model. Obvious OD decoloration. Edema of the OD and peripapillary retina. The 
boundaries of OD are not clear. There are spasm of arteries (filamentous arteries), dilation and tortuosity of veins, 
microaneurysms, hemorrhages. The overall background is pale. 
3 
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The eyes were completely removed along with the 
adjacent structures for morphometric examination and 
were fixed by immersion in 10% formalin solution. 
After fixing, the eyes were sectioned into two parts 
through the centre and both halves were processed 
into paraffin by routine methods. Also in the meridian 
direction, serial sections were made with a thickness 
of 5-7 μm, which were stained with haematoxylin and 
eosin. The stages of histological processing were 
performed using Leica equipment (Germany). For 
microscopy, morphometry and archiving, the prepared 
microslides were scanned using Mirax Desk, a 
computerised archiving and image analysis system. 
Image analysis and morphometry were carried out by 
a Pannoramic Viewer 1.15.4. The quantitative data 
were recorded in MS Excel spreadsheets. 
Calculation of the specific number of neuronal 
nuclei in the inner nuclear layer was carried out by 
Avtandilov G. point test on standard computer images 
obtained by the system for scanning and archiving 
images Mirax Desk and the program "Pannoramic 
Viewer" 1.15.4. A computer version of the 0.3 mm2 
grid projected on the image was used [8]. 
For all data, descriptive statistics were used, and 
the data were checked for normal distribution. 
Distribution type was determined by using the 
criterion of Shapiro-Wilk. In case of normal 
distribution, the average value (M) and standard error 
of the mean (m) were calculated. In cases of abnormal 
distribution, the median (Me) and the quartile range 
(QR) were calculated. Between-group differences 
were analyzed by parametric (t-Student criterion) or 
non-parametric (Mann-Whitney test) methods, 
depending on the type of distribution. Differences 
were determined at a 0.05 significance level. 
Statistical analyses were performed using Statistica 
10.0 software. 
Results 
Semi-quantitative Assessment of the Eye Fundus 
Condition. After 72 hours of reperfusion in all 
experimental groups rats were anesthetized for the 
study of  the eye fundus image. An example of an eye 
fundus of rat in intact group is shown in figure 1 A 
with the following description: OD is round, and 
against the background of the fundus its colour is 
pink. The boundaries of OD are clear. It is located in 
the plane of the retina. Out of the middle of the OD 
come the central vessels of the retina. Retinal vessels 
have no anastomoses. Veins and arteries are straight, 
the caliber is uniform, with no tortuosity. The overall 
background is pink. 
 
Figure-1: Eye fundus images of Wistar rats: A – from intact group; B – with the simulated retinal ischemia-
reperfusion. 
 
Example of the eye fundus of the laboratory rat 
with the simulated retinal ischemia-reperfusion is 
shown in figure 1 B with the following description: 
Obvious OD decoloration. Edema of the OD and 
peripapillary retina. The boundaries of OD are not 
clear. There are spasm of arteries, dilation of veins, 
hemorrhages. The overall background is pale. 
Ophthalmoscopic image with the correction of 
retinal ischemia-reperfusion by potassium salt of 
C7070 in a dose of 10 mg/kg is shown in figure 2 A 
and its description is close to normal. 
The observed protective effect in the eye fundus of 
laboratory rats with the correction by K+C7070 may 
be associated with the activation of ATP-dependent 
potassium channels, both in retinal vessels and in 
neurons, inhibition of Na+/H+ exchange channels  in 
retinal neurons, in turn leading to the suppression of 
apoptosis mechanisms. 
When the sodium salt of С7070 in a dose of 10 
mg/kg was administered to rats, for the correction of 
the simulated pathology the alignment of the retinal 
vessels caliber is observed, but the veins are plethoric, 
microaneurysms are not observed. The OD is slightly 
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increased in size, pink. The boundaries of OD are 
clear (Fig. 2 B). 
 
 
 
 
Figure-2: Eye fundus images of Wistar rats with correction of retinal ischemia-reperfusion: A – by 
potassium salt of С7070 in a dose of 10 mg/kg; B – by sodium salt of С7070 in a dose of 10 mg/kg. 
 
The observed protective effect of Na+C7070 
during ophthalmoscopy on the model of retinal 
ischemia-reperfusion probably has a similar 
mechanism with K+C7070, but the renoprotective 
effect of Na+C7070 in a dose of 10 mg/kg is less 
pronounced than that of K+C7070 in a dose of 10 
mg/kg, as partially vascular changes on the 
background of retinal ischemia are preserved. 
In the experimental groups with the injection of a 
potassium channels blocker  glibenclamide in 
correction of retinal ischemic damage by K+C7070 in 
a dose of 10 mg/kg and Na+C7070 in a dose of 10 
mg/kg, the spasm of the retinal arteries is observed. 
The state of OD is close to normal (Fig. 3). 
 
 
Figure-3: Eye fundus images of Wistar rats with the injection of glibenclamide in a dose of 5 mg/kg in 
correction of retinal ischemia-reperfusion: A – by potassium salt of С7070 in a dose of 10 mg/kg; B – by 
sodium salt of С7070 in a dose of 10 mg/kg. 
 
The results of the semi-quantitative assessment of 
the eye fundus state in the experimental groups are 
presented in Table 2. 
 
Table-2: Influence of potassium salt of С7070; sodium salt of С7070 on the results of assessment of 
changes in the eye fundus when correcting retinal ischemia-reperfusion (M±m; n=10), points. 
Experimental Groups Score 
1. Intact 0.2 ± 0.2 
2. Retinal ischemia-reperfusion model 2.8 ± 0.3* 
3. Ischemia-reperfusion + K+C7070, 10 mg/kg 0.2 ± 0.2 у 
4. Ischemia-reperfusion + Na+C7070, 10 mg/kg 0.8 ± 0.2 *у 
5. Ischemia-reperfusion + K+C7070, 10 mg/kg + glibenclamide, 5 mg/kg 1.1 ± 0.1*у 
6. Ischemia-reperfusion + Na+C7070, 10 mg/kg + glibenclamide, 5 mg/kg 1.2 ± 0.2*у 
* p < 0.05 compared to the intact; у p < 0.05 compared to the retinal ischemia-reperfusion model. 
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Based on the obtained data of the semi-quantitative 
assessment of the eye fundus state on the model of 
retinal ischemia-reperfusion in rats, it follows that the 
retinoprotective effect is in descending order: 
potassium salt of C7070 (10 mg/kg) > sodium salt 
C7070 (10 mg/kg). 
The observed protective effects of the studied 
substances, consisting in the correction of retinal 
artery spasm, may be associated with the activation of 
ATP-dependent potassium channels in the retinal 
vessels. The neuroprotective effect of the substances 
is probably related both to the inhibition of Na+/H+ 
exchange channels and to the activation of ATP-
dependent potassium channels in retinal neurons, 
which in turn leads to the inhibition of the 
mechanisms of apoptosis in the retina. 
Counting the Specific Number of Neuronal Nuclei 
in the Inner Nuclear Layer. The results of the 
counting the specific number of neuronal nuclei in the 
inner nuclear layer in the experimental groups are 
presented in table 3. 
 
Table-3: Influence of potassium salt of С7070; sodium salt of С7070 on the results of the countingthe 
specific number of neuronal nuclei in the inner nuclear layer when correcting retinal ischemia-reperfusion 
(M±m; n=10), absolute units. 
Experimental Groups 
Specific number of neuronal nuclei, 
absolute units 
1. Intact 12.2 ± 0.8у 
2. Retinal ischemia-reperfusion model 6.3 ± 0.6* 
3. Ischemia-reperfusion + K+C7070, 10 mg/kg 11.9 ± 0.8у 
4. Ischemia-reperfusion + Na+C7070, 10 mg/kg 11.0 ± 0.7у 
5. Ischemia-reperfusion + K+C7070, 10 mg/kg + glibenclamide, 
5 mg/kg 
10.5 ± 0.6у 
6. Ischemia-reperfusion + Na+C7070, 10 mg/kg + 
glibenclamide, 5 mg/kg 
9.4 ± 0.5*у 
* p < 0.05 compared to the intact; у p < 0.05 compared to the retinal ischemia-reperfusion model 
 
When modeling retinal pathology in the group, the 
mean specific number of neuronal nuclei in the inner 
nuclear layer significantly reduces by 48% (p < 0.05) 
in comparison with the group of intact animals. 
Against the background of the injection of K+C7070 
in a dose of 10 mg/kg, as well as Na+C7070 in a dose 
of 10 mg/kg, this indicator significantly increases by 
more than 74% (p < 0.05) in comparison with the 
group without correction, and does not significantly 
different from the intact group. With the injection of 
glibenclamide in the group with correction of 
ischemia by K+C7070 this indicator significantly 
increases by 67% (p < 0.05) in comparison with the 
mean value in the group without correction, but 
slightly decreases than value in the group with the 
injection of K+C7070 without glibenclamide. On the 
background of glibenclamide injection in the group 
with the correction by Na+C7070 this indicator  
significantly decreases in comparison with the value 
of the group of intact animals, by 23% (p < 0.05), 
significantly decreases in comparison with the mean 
value of the group with the injection of Na+C7070 (p 
< 0.05), but significantly increases in comparison with 
the mean in the group without correction. 
 
 
Discussion 
Previous studies showed that 2-(2-benzofuranyl)-
2-imidazoline (2-BFI), an immidazoline receptor 
ligand, dose-dependently protects rodent brains from 
cerebral ischemia injury. However, the molecular 
mechanisms remain unclear. In this study, was found 
that 2-BFI transiently and reversibly inhibits NMDA, 
but not AMPA currents, in a dose-dependent manner 
in cultured rat cortical neurons. 2-BFI also transiently 
and reversibly blocked NMDA receptor-mediated 
calcium entry to cultured neurons and provided long-
term neuroprotection against NMDA toxicity in vitro. 
Collectively, these studies demonstrated a potential 
mechanism of 2-BFI-mediated neuroprotection and 
indicated that 2-BFI is an excellent candidate for 
repositioning as a drug for stroke treatment [14]. 
It is known that activation of IR of type II reduces 
the voltage-dependent activation of Ca2+ channels in 
neurons innervating the blood vessels [15]. 
As a result of a series of experiments on cell 
cultures of insulinoma RIN-5AH, it was shown that 
the insulin secretagogue function of pancreatic β-cells 
is increased by the action of imidazoline compounds 
even with selective blocking of I1R and I2R. This 
research has indicated the presence of another 
imidazoline-sensitive receptor and initiated the 
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investigation of I3R. Since the addition of an activator 
of K+-ATP-dependent diazoxin channels prevents 
insulinolysis, it is considered that I3R performs its 
function through regulation of K+ and Ca2+ 
concentrations of Langerhans cells. Later, β-carboline 
Harmane was found as its selective agonist [16]. 
In the future it would be interesting to study the 
distribution of potassium salt of С7070, sodium salt of 
С7070 in the eye tissue with use high performance 
liquid chromatography with mass spectrometric 
detection [17] and possibility of correction the retinal 
microcirculation by studied substances with use laser 
Doppler flowmetry [18-22]. 
In connection with the foregoing, the proposed 
mechanism of neuroretinoprotection of IR-agonist of 
type II can be associated with the inhibition of Na+/H+ 
exchange channels in the retinal neurons, the 
inhibition of NMDA receptors; type III – with the 
activation of ATP-sensitive potassium channels in 
blood vessels and retinal neurons [23-25]. 
Conclusion 
Probably, ATP-sensitive potassium channels make 
a great contribution to the realization of 
neuroretinoprotective effects of the studied IR-
ligands: sodium salt of C7070, potassium salt of 
C7070 since their blockade by glibenclamide leads to 
partial elimination of the positive dynamics of 
ophthalmoscopic and morphometric parameters in 
retina during the correction of retinal ischemia-
reperfusion by the studied substances. 
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